Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for Journal of Ophthalmology, enter your email address in the box below.

Journal of Ophthalmology
Volume 2014, Article ID 689792, 4 pages
http://dx.doi.org/10.1155/2014/689792
Research Article

The Anti-Acetylcholine Receptor Antibody Test in Suspected Ocular Myasthenia Gravis

Jung Jin Lee,1 Kyung Min Koh,1 and Ungsoo Samuel Kim1,2

1Department of Ophthalmology, Kim’s Eye Hospital, Konyang University College of Medicine, Youngdeungpo 4th 156, Youngdeungpo-gu, Seoul 150-034, Republic of Korea
2Department of Ophthalmology, Konyang University College of Medicine, Daejeon 302-718, Republic of Korea

Received 16 August 2014; Revised 18 October 2014; Accepted 29 October 2014; Published 13 November 2014

Academic Editor: Miguel Cordero-Coma

Copyright © 2014 Jung Jin Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. B. M. Kuks, P. C. Limburg, G. Horst, J. Dijksterhuis, and H. J. G. H. Oosterhuis, “Antibodies to skeletal muscle in myasthenia gravis. Part 1. Diagnostic value for the detection of thymoma,” Journal of the Neurological Sciences, vol. 119, no. 2, pp. 183–188, 1993. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Ööpik, L. Puksa, S.-M. Lüüs, A.-E. Kaasik, and J. Jakobsen, “Clinical and laboratory-reconfirmed myasthenia gravis: a population-based study,” European Journal of Neurology, vol. 15, no. 3, pp. 246–252, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Benatar and H. J. Kaminski, “Evidence report: the medical treatment of ocular myasthenia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology,” Neurology, vol. 68, no. 24, pp. 2144–2149, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. M. J. Kupersmith, R. Latkany, and P. Homel, “Development of generalized disease at 2 years in patients with ocular myasthenia gravis,” Archives of Neurology, vol. 60, no. 2, pp. 243–248, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Benatar, “A systematic review of diagnostic studies in myasthenia gravis,” Neuromuscular Disorders, vol. 16, no. 7, pp. 459–467, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. A. G. Engel, “Myasthenia gravis and myasthenic syndromes,” Annals of Neurology, vol. 16, no. 5, pp. 519–534, 1984. View at Publisher · View at Google Scholar · View at Scopus
  7. Z.-F. Mao, L.-X. Yang, X.-A. Mo et al., “Frequency of autoimmune diseases in myasthenia gravis: a systematic review,” International Journal of Neuroscience, vol. 121, no. 3, pp. 121–129, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Vincent and J. Newsom-Davis, “Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 48, no. 12, pp. 1246–1252, 1985. View at Publisher · View at Google Scholar · View at Scopus
  9. P. C. Limburg, T. H. The, E. Hummel Tappel, and H. J. G. H. Oosterhuis, “Anti-acetylcholine receptor antibodies in myasthenia gravis. Part I. Relation to clinical parameters in 250 patients,” Journal of the Neurological Sciences, vol. 58, no. 3, pp. 357–370, 1983. View at Publisher · View at Google Scholar · View at Scopus
  10. M. K. Mittal, R. J. Barohn, M. Pasnoor et al., “Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response,” Journal of Clinical Neuromuscular Disease, vol. 13, no. 1, pp. 46–52, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Cleary, G. J. Williams, and R. A. Metcalfe, “The pattern of extra-ocular muscle involvement in ocular myasthenia,” Strabismus, vol. 16, no. 1, pp. 11–18, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. H. J. G. H. Oosterhuis, “The ocular signs and symptoms of myasthenia gravis,” Documenta Ophthalmologica, vol. 52, no. 3-4, pp. 363–378, 1982. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Nakamura, T. Usa, M. Motomura et al., “Prevalence of interrelated autoantibodies in thyroid diseases and autoimmune disorders,” Journal of Endocrinological Investigation, vol. 31, no. 10, pp. 861–865, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. E. Seybold, “Myasthenia gravis. A clinical and basic science review,” The Journal of the American Medical Association, vol. 250, no. 18, pp. 2516–2521, 1983. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Yaman and H. Yaman, “Ocular myasthenia gravis coincident with thyroid ophthalmopathy,” Neurology India, vol. 51, no. 1, pp. 100–101, 2003. View at Google Scholar · View at Scopus
  16. I. M. Cojocaru, M. Cojocaru, and C. Muşuroi, “Study of anti-striational and anti-thyroid antibodies in patients with myasthenia gravis,” Romanian Journal of Internal Medicine, vol. 38-39, pp. 111–120, 2000. View at Google Scholar · View at Scopus
  17. A. Polymeris, E. Karoutsou, and K. Doumouchtsis, “Seronegative myasthenia gravis and Graves' disease. Is there a link?” Experimental and Clinical Endocrinology and Diabetes, vol. 120, no. 5, pp. 254–256, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. M. J. Kupersmith, M. Moster, S. Bhiiiyan, F. Warren, and H. Weinberg, “Beneficial effects of corticosteroids on ocular myasthenia gravis,” Archives of Neurology, vol. 53, no. 8, pp. 802–804, 1996. View at Publisher · View at Google Scholar · View at Scopus